7.99
price down icon0.62%   -0.05
 
loading
Precedente Chiudi:
$8.04
Aprire:
$8
Volume 24 ore:
256.33K
Relative Volume:
0.73
Capitalizzazione di mercato:
$183.96M
Reddito:
-
Utile/perdita netta:
$-52.07M
Rapporto P/E:
-38.47
EPS:
-0.2077
Flusso di cassa netto:
$-44.93M
1 W Prestazione:
-3.97%
1M Prestazione:
-3.27%
6M Prestazione:
-20.34%
1 anno Prestazione:
-26.33%
Intervallo 1D:
Value
$7.80
$8.0699
Intervallo di 1 settimana:
Value
$7.55
$8.84
Portata 52W:
Value
$4.81
$13.88

Cybin Inc Stock (CYBN) Company Profile

Name
Nome
Cybin Inc
Name
Telefono
908 764 8385
Name
Indirizzo
100 King Street West, Suite 5600, Toronto
Name
Dipendente
38
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CYBN's Discussions on Twitter

Confronta CYBN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CYBN
Cybin Inc
7.99 185.19M 0 -52.07M -44.93M -0.2077
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Guggenheim Buy
2021-11-19 Downgrade Maxim Group Buy → Hold

Cybin Inc Borsa (CYBN) Ultime notizie

pulisher
12:11 PM

What are the technical indicators suggesting about Cybin Inc.Access high-yield investment alerts now - jammulinksnews.com

12:11 PM
pulisher
08:43 AM

Should I hold or sell Cybin Inc. stock in 2025Extraordinary performance - jammulinksnews.com

08:43 AM
pulisher
Jul 26, 2025

How Cybin Inc. stock performs during market volatilitySolid Return Trade Selections - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Cybin Inc. stockSuperior portfolio returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Cybin Inc. Stock Analysis and ForecastFree Capital Efficiency Planning - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Cybin Inc. a good long term investmentExceptional growth trajectory - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Cybin, Inc: CYB003 Vs. GH001Duration, Durability and Protocol Execution - Smartkarma

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Cybin Inc. stock pricePowerful market insights - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Cybin Inc. stock benefit from AI tech trendsFree Predictions - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

I can have 5% loss. - AInvest

Jul 24, 2025
pulisher
Jul 21, 2025

(CYBN) Proactive Strategies - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 21, 2025

High-Risk, High-Reward Stocks With Serious Momentum: 5 Stocks to Consider - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Cybin Inc: CYB003 Phase 3 Program Continues to Progress on Plan - Smartkarma

Jul 21, 2025
pulisher
Jul 20, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jul 20, 2025
pulisher
Jul 18, 2025

Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money

Jul 18, 2025
pulisher
Jul 18, 2025

Wall Street Analysts See an 831.44% Upside in Cybin Inc. (CYBN): Can the Stock Really Move This High? - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

UK MHRA approves Cybin’s trial of CYB003 for major depressive disorder - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Three High-Risk, High-Reward Stocks in AI, Biotech, and Autonomous Vehicles - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin's EMBRACE Study: A Pivotal Step in Psychedelic-Driven Mental Healthcare Innovation - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin receives UK MHRA approval to commence EMBRACE study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin Secures UK Approval for Pivotal Depression Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin receives UK approval for second pivotal depression study By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin receives UK approval for second pivotal depression study - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin Receives UK MHRA Approval To Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 For The Adjunctive Treatment Of Major Depressive Disorder - TradingView

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - FinancialContent

Jul 17, 2025
pulisher
Jul 16, 2025

3 High-Risk, High-Reward Stocks With Explosive Upside - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

Three High-Risk, High-Reward Stocks with Explosive Upside: Rezolve AI, Aurora Innovation, and Cybin Inc. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Cybin, Inc.CYB003 Vs. Other Aspiring Novel Depression Treatments - Smartkarma

Jul 16, 2025
pulisher
Jul 15, 2025

Cybin Inc. Expands Market Strategy with New SEC Filing - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

Cybin, Inc: Not All Psychedelic Treatments for Depression Are Created Equal - Smartkarma

Jul 14, 2025

Cybin Inc Azioni (CYBN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):